Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2024

Oct 4, 2024

30561_dirs_2024-10-03_c25a6b34-d0ff-435c-b0f2-7f3b0e636c0d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-10-02

Reporting Person: Haley Patrick J. (EVP, Commercial)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-10-02 Common Stock M 100000 $24.41 Acquired 441036 Direct
2024-10-02 Common Stock F 96111 $26.50 Disposed 344925 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-10-02 Option (right to buy) $24.41 M 100000 Disposed 2024-10-02 Common Stock (100000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10648 Indirect
Common Stock 23539 Indirect

Footnotes

F1: Includes 239,572 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

F2: Represents a "net exercise" of an outstanding stock option to purchase 100,000 shares, and pursuant to which the Reporting Person received 3,889 shares, of Common Stock. The Issuer withheld 96,111 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing stock price on October 2, 2024 of $26.50.

F3: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of October 1, 2024.

F4: The option, representing the right to purchase a total of 100,000 shares of Common Stock, became fully exercisable on October 3, 2021.